Shanghai HeartCare Medical Technology (HKSE:06609) Property, Plant and Equipment: HK$89.4 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06609 Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
80 GF Score
Price HK$45.92
GF Value HK$54.97
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Shanghai HeartCare Medical Technology Property, Plant and Equipment?

Shanghai HeartCare Medical Technology HKSE:06609 -2.26% 80 Property, Plant and Equipment is HK$89.4 Mil as of Dec. 2025. GuruFocus rates HKSE:06609 with a GF Score™ of 80/100 and a GF Value™ of HK$54.97 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Shanghai HeartCare Medical Technology's quarterly net PPE increased from Dec. 2024 (HK$87.1 Mil) to Jun. 2025 (HK$94.4 Mil) but then declined from Jun. 2025 (HK$94.4 Mil) to Dec. 2025 (HK$89.4 Mil).

Shanghai HeartCare Medical Technology's annual net PPE declined from Dec. 2023 (HK$109.0 Mil) to Dec. 2024 (HK$87.1 Mil) but then increased from Dec. 2024 (HK$87.1 Mil) to Dec. 2025 (HK$89.4 Mil).


Shanghai HeartCare Medical Technology  (HKSE:06609) Property, Plant and Equipment Explanation

A company with durable competitive advantage doesn't need to constantly upgrade its equipment to stay competitive. The company replaces when it wears out. On the other hand, a company without any advantages must replace to keep pace.

Difference between a company with a moat and one without is that the company with the competitive advantage finances new equipment through internal cash flows, whereas the no advantage company requires debt to finance.

Producing a consistent product that doesn't change equates to consistent profits. There is no need to upgrade plants which frees up cash for other ventures. Think Coca Cola, Johnson & Johnson etc.


Shanghai HeartCare Medical Technology Property, Plant and Equipment Related Terms


Shanghai HeartCare Medical Technology Property, Plant and Equipment Historical Data

* Premium members only.

The historical data trend for Shanghai HeartCare Medical Technology's Property, Plant and Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai HeartCare Medical Technology Property, Plant and Equipment Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Property, Plant and Equipment
Get a 7-Day Free Trial 141.82 140.25 109.02 87.10 89.43

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Property, Plant and Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 137.10 87.10 94.38 89.43 82.63
HKSE:06609
80GF Score
Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
Property, Plant and Equipment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai HeartCare Medical Technology Property, Plant and Equipment Calculation

Property, Plant and Equipment (PPE) are the fixed assets of the companyFixed assets are also known as non-current assets.

Property, plant, and equipment includes assets that will - in the normal course of business - neither be used up in the next year nor will become a part of any product sold to customers.

Some of the most common parts of property, plant, and equipment are:


Land
Buildings (and leasehold improvements)
Transportation equipment
Manufacturing equipment
Office equipment
Office furniture

Companies with lots of property, plant, and equipment often have special categories. For example, railroad property includes:


Track
Ties
Ballast
Bridges
Tunnels
Signals
Locomotives
Freight Cars

There is often a note in the financial statements - found in a company's 10-K - that will explain the different categories of property a company owns.

The market value of property, plant, and equipment can differ tremendously from the book value of property, plant, and equipment.

For example, when Berkshire Hathaway liquidated its textile mills, it had to pay the buyers of the company's manufacturing equipment to haul the equipment away. That property, plant, and equipment was literally worth less than zero. On the other hand, some companies own thousands of acres of land.

All property, plant, and equipment other than land is depreciated. Land is never depreciated. However, land is not marked up to market value either. Under Generally Accepted Accounting Principles (GAAP), land is shown on the balance sheet at cost.

The property, plant, and equipment line shown on the balance sheet is usually net property, plant, and equipment. This means it is the cost of the property, plant, and equipment less accumulated depreciation.

What does a Property, Plant and Equipment of HK$89.4 Mil mean?
Shanghai HeartCare Medical Technology (HKSE:06609) has a Property, Plant and Equipment of HK$89.4 Mil as of Dec. 2025. The total property, plant and equipment recorded on a company's balance sheet less accumulated depreciation. View historical data on Shanghai HeartCare Medical Technology and its competitors.
Is Shanghai HeartCare Medical Technology's Property, Plant and Equipment too high?
Shanghai HeartCare Medical Technology's current Property, Plant and Equipment is HK$89.4 Mil. Overall, Shanghai HeartCare Medical Technology has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai HeartCare Medical Technology's Property, Plant and Equipment compare to ABT and SYK?
Shanghai HeartCare Medical Technology's Property, Plant and Equipment of HK$89.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Property, Plant and Equipment for a Medical Devices & Instruments company?
A good Property, Plant and Equipment depends on the Medical Devices & Instruments industry context. However, Property, Plant and Equipment should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Property, Plant and Equipment mean?
A high Property, Plant and Equipment can signal that a stock is expensive relative to its fundamentals. The total property, plant and equipment recorded on a company's balance sheet less accumulated depreciation. View historical data on Shanghai HeartCare Medical Technology and its competitors. Shanghai HeartCare Medical Technology's current Property, Plant and Equipment is HK$89.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai HeartCare Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology (HKSE:06609) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$54.97, compared to a current price of HK$45.92 — trading 16.5% below its estimated fair value. The current Property, Plant and Equipment is HK$89.4 Mil. Shanghai HeartCare Medical Technology's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Property, Plant and Equipment calculated?
Property, Plant and Equipment is calculated from a company's financial statements. For Shanghai HeartCare Medical Technology (HKSE:06609), the current Property, Plant and Equipment is HK$89.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai HeartCare Medical Technology (HKSE:06609) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology stock appears to be undervalued. The current stock price of HK$45.92 is trading 16.5% below its estimated GF Value™ of HK$54.97. GuruFocus considers Shanghai HeartCare Medical Technology to be Modestly Undervalued.

Key valuation signals for HKSE:06609:

  • Property, Plant and Equipment: HK$89.4 Mil
  • GF Value™: HK$54.97 vs. price of HK$45.92 (16.5% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the HKSE:06609 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai HeartCare Medical Technology Business Description

Address No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
80GF Score

Get the complete analysis for HKSE:06609

Property, Plant and Equipment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$45.92
Price
HK$54.97
GF Value